Towards a democratic era of medicine, with Simon Kohl
In a new episode, Simon Kohl discusses Latent Labs’ emergence from stealth, as well as protein design and drug discovery acceleration in more detail.
Newsletters and Deep Dive digital magazine
In a new episode, Simon Kohl discusses Latent Labs’ emergence from stealth, as well as protein design and drug discovery acceleration in more detail.
At ESMO 2025 in Berlin, VML Health presented the inaugural Patient Advocacy Summit.
At Frontiers Health 2025, Drew McCormick, Head of Data and Analytics at EVERSANA, emphasised a critical truth: data strategy is launch strategy.
Sigma Mostafa, CSO at KBI BioPharma, discusses the role of CDMOs and the important factors companies should consider when selecting one.
With demand for cell and gene therapies (CGTs) growing rapidly, blood centres are indispensable collaborators.
Editor's Picks
Newsletters and Deep Dive
digital magazine